As practices reopen we are bombarded with testing options for covid, and no way to understand which ones are meaningful and which ones are worthless. 

The answers to already exist from large scale testing validation and screening programs in hospitals and outpatient primary care networks in the hot zones. 

Learn from experts in New York, Italy, Korea, and Connecticut and use their protocols to protect your patients and yourself.

• What are the testing methods-how do they differ
• Which is helpful? saliva/nasal RNA? Serum IgG?
• When and how should staff and patients be tested
• How to incorporate testing to make a meaningful difference and avoid false reassurances

Find out how testing will fit into your larger strategy of patient care and triage as you reopen.
Stay safe and protect your patients!

• Mark Jarrett, MD MPH Senior Vice President and Chief Quality Officer, Northwell Health, Deputy Chief Medical Officer, Professor, Medicine--29 hospital network in NY having already tested 10,000 positive patients - largest experience in USA 72,000 employees and will discuss population testing, primary care office testing and employee testing
• L. Scott Sussman, MD  Senior Medical Director, Clinical Operations, Yale New Haven Health; Yale School of Medicine responsible for testing protocols inpatient in in primary care offices reopening
• Amy Compton-Phillips, M.D., executive vice president and chief clinical officer Providence Health Seattle - first USA hot zone, 59 hospital network of over 24,000 employees
• Davide Abate, MD Professor of Microbiology and Virology University of Padova Northern Italy--responsible for population screening studies
• David Peaper, MD, PhD Prof Lab Med; Director, Clinical Microbiology Laboratory, Yale,  Director, Microbiology Fellowship; Director, Virology Reference Laboratory